Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Der Pathologe|November 6, 2020
[Invariant natural killer T cells : Cellular immune regulators with cytotoxic potential]Dominik Schneidawind
Blood|September 27, 2013
Regulatory T cells and natural killer T cells for modulation of GVHD following allogeneic hematopoietic cell transplantationDominik Schneidawind, Antonio Pierini, Robert S Negrin
Current Stem Cell Reports|January 19, 2016
Regulatory T Cell Immunotherapy in Immune-Mediated DiseasesAntonio Pierini, Dominik Schneidawind, Hidekazu Nishikii, et al.
Frontiers in Immunology|May 8, 2026
Extracorporeal photopheresis alone or in combination with ruxolitinib for the treatment of chronic graft-versus-host diseaseChristian Koch, Markus G Manz, Mirjam Nägeli, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 17, 2024
Extracorporeal cytokine adsorption as therapeutic option for immune effector cell-associated neurotoxicity syndromeAlix Buhlmann, Emanuel Rom, Giovanna Schweiger, et al.
Annals of Hematology|August 2, 2018
Second allogeneic hematopoietic cell transplantation enables long-term disease-free survival in relapsed acute leukemiaCorina Schneidawind, Volker Hagmaier, Christoph Faul, et al.
Annals of Hematology|May 9, 2013
Allogeneic hematopoietic cell transplantation with reduced-intensity conditioning following FLAMSA for primary refractory or relapsed acute myeloid leukemiaDominik Schneidawind, Birgit Federmann, Christoph Faul, et al.
Leukemia & Lymphoma|April 8, 2010
Polyomavirus BK-specific CD8+ T cell responses in patients after allogeneic stem cell transplantDominik Schneidawind, Anita Schmitt, Markus Wiesneth, et al.
European Journal of Haematology|November 6, 2024
Inferior Overall Survival After Haploidentical Donor Lymphocyte Infusions in Relapsed Myeloid NeoplasmsTobias Matthieu Benoit, Adrian Bachofner, Nathan Wolfensberger, et al.
Clinical Transplantation|May 5, 2017
Follow-up of patients with refractory or relapsed multiple myeloma after allogeneic hematopoietic cell transplantationCorina Schneidawind, Silke Duerr-Stoerzer, Christoph Faul, et al.
Pageof 6